AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

Dr. Marwan G. Fakih discussed the FDA approval of Lumakras with Vectibix for third-line treatment of KRAS G12C-mutated ...

The research, led by CCU Department of Physiology Chair Professor Tsai Shaw-jenq and NCKU College of Medicine Dean Shan ...

Researchers from Taiwan crack the code of pancreatic cancer’s growth. Could this discovery finally lead to a breakthrough in pancreatic cancer treatment?

The American Association for Cancer Research Annual Meeting 2025 will be held from April 25-30 in Chicago, Illinois, providing a valuable platform for the oncology community to share and discuss the ...

The focus of the presentation will be on the subgroup of patients who have received 100mg bezuclastinib for at least 48 weeks to highlight the symptomatic benefits of long-term use.

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Researchers from National Chung Cheng University (CCU) and National Cheng Kung University (NCKU) have identified a novel signaling mechanism in pancreatic cancer patients, knowledge of which might ...

Industries are revolutionised by the intervention of Artificial Intelligence (AI) in all dimensions and domains of business ...

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

Precision medicines biotech Frontier Medicines is leaving behind an unknown number of staffers as it refocuses resources to ...

Global markets have recently experienced a mix of volatility and growth, with U.S. stocks facing challenges from competitive pressures in the AI sector and political uncertainties surrounding tariffs, ...